merck sales - Search News

Merck 2025 sales forecast underwhelms

The Associated Press - Busines… · 1d

Merck 2025 sales forecast underwhelms as it pauses Gardasil sales in China

Shares of Merck are sliding in early trading after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales forecast due partly to a pause in shipments of one of its top-selling products to China.

Hosted on MSN · 1d

Merck Stock Tumbles on Weak Guidance, Bad News in China for Gardasil Sales

Merck’s problems in China seem to be getting worse, raising questions about the company’s growth. Trouble with sales of Merck’s Gardasil HPV vaccine in China, disclosed six months ago, has unsettled investors,

Euronews (English) on MSN · 1d

Merck sales forecast underwhelms as it pauses some shipments in China

Shares of Merck slid on Tuesday in early trading after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales forecast due partly to a pause in shipments of one of its top-selling products to China.

Merck stock slides

Merck beats estimates on fourth-quarter on earnings—but stock slides pre-market on tepid 2025 guidance

Merck ( MRK) reported fourth quarter and full year earnings Tuesday, in line with Wall Street estimates. The bad news: Its stock was down more than 8% in pre-market trading, largely because of weaker than expected 2025 guidance.

Seeking Alpha · 1d

Merck stock slides as 2025 earnings outlook misses estimates

Merck (MRK) shares drop 8% premarket as 2025 outlook falls short of Wall Street estimates, despite beating Q4 expectations with Keytruda sales.

The Wall Street Journal on MSN · 1d

Merck Earnings Rise; 2025 Outlook Hits Shares

Merck swung to a quarterly profit as sales grew to beat Wall Street’s estimates, although the drug company’s outlook for 2025 and a slide in sales of its HPV vaccine hit shares.

1don MSN

Merck Sales Increase Results in Swing to Profit

Merck swung to a fourth-quarter profit as sales grew and even exceeded Wall Street’s estimates, boosted in part by the ...

Merck’s earnings miss focused attention on Gardasil. The real issue is Keytruda

Merck on Tuesday missed earnings estimates, lowered its guidance for this year’s earnings, and withdrew a target for sales of ...

Merck halts Gardasil shipments to China, withdraws $11B sales target as demand nosedives

The continued decline of Merck & Co.’s HPV vaccine Gardasil in China has come to a head as the New Jersey drug giant is ...

4hon MSN

Merck Is Suffering From a Classic Pharma Problem

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

1h

Should You Pick MRK Stock At $90?

Merck (NYSE: MRK) recently released its Q4 results, with revenues and earnings exceeding the street estimates.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results